Placing value, price on new drugs: The challenge facing new UK policy, say Hopkins bioethicists
Friday, April 1, 2011 - 10:01
in Psychology & Sociology
The United States should pay close attention to how the United Kingdom carries out plans to assess a new drug's worth using factors that go beyond clinical and cost effectiveness, according to researchers at the Johns Hopkins Berman Institute of Bioethics.